000 01350 a2200421 4500
005 20250513125258.0
264 0 _c19971105
008 199711s 0 0 eng d
022 _a0960-3271
024 7 _a10.1177/096032719701600906
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMartin, F
245 0 0 _aOrganotin compounds in trimethyltin-treated rats and in human brain in Alzheimer's disease.
_h[electronic resource]
260 _bHuman & experimental toxicology
_cSep 1997
300 _a512-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAlzheimer Disease
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aBrain
_xmetabolism
650 0 4 _aChromatography, Gas
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIndicators and Reagents
650 0 4 _aMale
650 0 4 _aOrganotin Compounds
_xanalysis
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aSpectrophotometry, Atomic
650 0 4 _aTrimethyltin Compounds
_xpharmacokinetics
700 1 _aCorrigan, F M
700 1 _aDonard, O F
700 1 _aKelly, J
700 1 _aBesson, J A
700 1 _aHorrobin, D F
773 0 _tHuman & experimental toxicology
_gvol. 16
_gno. 9
_gp. 512-5
856 4 0 _uhttps://doi.org/10.1177/096032719701600906
_zAvailable from publisher's website
999 _c9284305
_d9284305